Received Oct 8, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HPV9 | HPV (GARDASIL 9) | MERCK & CO. INC. | 1 | — | OT |
No additional AE; patient received the first dose of GARDASIL9 at a different provider's office on 07/25/2025 and the patient was 50 years old at that time; This spontaneous report was received from a nurse and refers to a 50-year-old female patient. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On 25-Jul-2025, at the age of 50-year-old, the patient was vaccinated at a different provider's office with the first dose of Human Papillomavirus 9-valent Vaccine, Recombinant (GARDASIL 9) (dose, route of administration, anatomical site, lot # and expiration date were not reported) as prophylaxis (Product administered to patient of inappropriate age). She went to nurse's office requesting a second dose of Human Papillomavirus 9-valent Vaccine, Recombinant (GARDASIL 9). The nurse reported the second dose was not administered due to the patient's age. No additional adverse event reported (No adverse event). Batch/Lot number is being requested and will be submitted if received.